{"success":true,"data":{"pressRelease":{"id":"166760","rtpr_id":"nGNX7XpLwD-20261012","ticker":"LFVN","exchange":"NASDAQ","all_tickers":["LFVN"],"title":"LifeVantage Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)","author":"Globe Newswire","published_at":"2026-10-12T20:05:00.171Z","article_body":"SALT LAKE CITY, Oct. 12, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation\n(Nasdaq: LFVN) (“LifeVantage” or the “Company”) today announced that\nits Board of Directors granted inducement awards to Terrence Moorehead, the\nCompany’s President and Chief Executive Officer, under the Company’s 2026\nNew Employee Long-Term Incentive Plan. The awards were granted pursuant to the\nkey executive benefits agreement between the Company and Mr. Moorehead, dated\nas of April 15, 2026, as an inducement material to Mr. Moorehead’s\nemployment in accordance with Nasdaq Listing Rule 5635(c)(4).\n\nThe awards were granted on October 7, 2026 and consist of (i) a grant of\nrestricted stock units (“RSUs”) representing 128,824 shares of the\nCompany’s common stock, which will vest in three equal annual installments\nstarting on the one-year anniversary of their grant date and (ii) a grant of\nperformance-based restricted stock units (“PSUs”) representing 193,237\nshares of the Company’s common stock at target (or up to 289,855 shares if\nmaximum performance is achieved), which will vest based on the achievement of\ncertain revenue and Adjusted EBITDA margin targets during a 3.5-year\nperformance period, in each case, subject to continued service with the\nCompany through the applicable vesting dates.\n\nAbout LifeVantage Corporation\n\nLifeVantage Corporation (Nasdaq: LFVN), the Activation company, is a pioneer\nin nutrigenomics-the study of how nutrition and naturally occurring compounds\ncan unlock your genes and the health coded within. Our products work with your\nunique biology and help your body make what it needs for health. The line of\nscientifically validated activators includes the flagship Protandim(®) family\nof products, TrueScience(®) Liquid Collagen, the MindBody GLP-1 System(®),\nthe comprehensive gut activator P84, the Activation-supporting nutrients such\nas Omega, D3+, and the Rise AM & Reset PM System(®), as well as AXIO(®)\nnootropic energy drink mixes, the full TrueScience(®) line of skin and hair\ncare products, and Petandim(®), a pet supplement formulated to combat\noxidative stress in dogs. Our independent Consultants sell our products to\nCustomers and share the business opportunity with entrepreneurs seeking to\nbegin their own business. LifeVantage was founded in 2003 and is headquartered\nin Lehi, Utah. For more information, visit www.lifevantage.com.\n\nInvestor Relations Contacts:\n\nReed Anderson, ICR\n(646) 277-1260\nreed.anderson@icrinc.com\n\n(https://www.globenewswire.com/NewsRoom/AttachmentNg/0a4e0557-7f26-4cc2-a809-4b32c6b0c2d1)\n\n\n\nGlobeNewswire, Inc. 2026","article_body_html":"","raw_payload":{"data":{"id":"nGNX7XpLwD-20261012","title":"LifeVantage Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)","author":"Globe Newswire","ticker":"LFVN","created":"2026-10-12T20:05:00.171Z","tickers":["LFVN"],"exchange":"NASDAQ","article_body":"SALT LAKE CITY, Oct. 12, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation\n(Nasdaq: LFVN) (“LifeVantage” or the “Company”) today announced that\nits Board of Directors granted inducement awards to Terrence Moorehead, the\nCompany’s President and Chief Executive Officer, under the Company’s 2026\nNew Employee Long-Term Incentive Plan. The awards were granted pursuant to the\nkey executive benefits agreement between the Company and Mr. Moorehead, dated\nas of April 15, 2026, as an inducement material to Mr. Moorehead’s\nemployment in accordance with Nasdaq Listing Rule 5635(c)(4).\n\nThe awards were granted on October 7, 2026 and consist of (i) a grant of\nrestricted stock units (“RSUs”) representing 128,824 shares of the\nCompany’s common stock, which will vest in three equal annual installments\nstarting on the one-year anniversary of their grant date and (ii) a grant of\nperformance-based restricted stock units (“PSUs”) representing 193,237\nshares of the Company’s common stock at target (or up to 289,855 shares if\nmaximum performance is achieved), which will vest based on the achievement of\ncertain revenue and Adjusted EBITDA margin targets during a 3.5-year\nperformance period, in each case, subject to continued service with the\nCompany through the applicable vesting dates.\n\nAbout LifeVantage Corporation\n\nLifeVantage Corporation (Nasdaq: LFVN), the Activation company, is a pioneer\nin nutrigenomics-the study of how nutrition and naturally occurring compounds\ncan unlock your genes and the health coded within. Our products work with your\nunique biology and help your body make what it needs for health. The line of\nscientifically validated activators includes the flagship Protandim(®) family\nof products, TrueScience(®) Liquid Collagen, the MindBody GLP-1 System(®),\nthe comprehensive gut activator P84, the Activation-supporting nutrients such\nas Omega, D3+, and the Rise AM & Reset PM System(®), as well as AXIO(®)\nnootropic energy drink mixes, the full TrueScience(®) line of skin and hair\ncare products, and Petandim(®), a pet supplement formulated to combat\noxidative stress in dogs. Our independent Consultants sell our products to\nCustomers and share the business opportunity with entrepreneurs seeking to\nbegin their own business. LifeVantage was founded in 2003 and is headquartered\nin Lehi, Utah. For more information, visit www.lifevantage.com.\n\nInvestor Relations Contacts:\n\nReed Anderson, ICR\n(646) 277-1260\nreed.anderson@icrinc.com\n\n(https://www.globenewswire.com/NewsRoom/AttachmentNg/0a4e0557-7f26-4cc2-a809-4b32c6b0c2d1)\n\n\n\nGlobeNewswire, Inc. 2026"},"type":"article","timestamp":"2026-10-12T20:05:00.205135235Z","server_sent_at_ms":1791835500205},"received_at":"2026-10-12T20:05:00.353Z","source_url":null},"analysis":{"id":"155103","press_release_id":"166760","analysis_json":{"industry":{"label":"Personal Care Products","sector":"Consumer Staples"},"redFlags":[],"eventType":"board_change","narrative":"LifeVantage's board granted CEO Terrence Moorehead inducement equity awards under the 2026 New Employee Long-Term Incentive Plan, per his April 15, 2026 employment agreement.\n\nThe package includes RSUs for 128,824 shares vesting over three years and performance RSUs for 193,237 shares at target (up to 289,855 at max), tied to revenue and Adjusted EBITDA margin targets over 3.5 years.\n\nThis is a routine Nasdaq Listing Rule 5635(c)(4) disclosure formalizing previously agreed CEO compensation; no new financial or strategic information was provided.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Routine CEO inducement grant disclosure -- suppress."},"keyFigures":{"customDimensions":{"rsu_shares":128824,"psu_shares_max":289855,"psu_shares_target":193237}},"namedEntities":{"people":[{"name":"Terrence Moorehead","role":"President and CEO"}],"products":["Protandim","TrueScience Liquid Collagen","MindBody GLP-1 System","AXIO","Petandim"],"companies":[{"name":"LifeVantage Corporation","ticker":"LFVN"}],"dollarAmounts":[]},"materialImpact":{"score":1,"reasoning":"Boilerplate Nasdaq 5635(c)(4) inducement grant disclosure for CEO Terrence Moorehead's employment agreement. No change in compensation economics beyond what was agreed in April 2026; no new strategic or financial information."},"tickerRelevance":{"others":[],"primary":"LFVN"},"globalImportance":8,"audienceRelevance":8,"eventTypeSecondary":["executive_change"],"importanceComponents":{"tickerTier":"small-cap","eventGravity":"boilerplate-equity-grant","issuerAuthored":true}},"event_type":"board_change","event_type_secondary":["executive_change"],"sentiment":"neutral","material_impact_score":1,"narrative":"LifeVantage's board granted CEO Terrence Moorehead inducement equity awards under the 2026 New Employee Long-Term Incentive Plan, per his April 15, 2026 employment agreement.\n\nThe package includes RSUs for 128,824 shares vesting over three years and performance RSUs for 193,237 shares at target (up to 289,855 at max), tied to revenue and Adjusted EBITDA margin targets over 3.5 years.\n\nThis is a routine Nasdaq Listing Rule 5635(c)(4) disclosure formalizing previously agreed CEO compensation; no new financial or strategic information was provided.","key_figures":{"customDimensions":{"rsu_shares":128824,"psu_shares_max":289855,"psu_shares_target":193237}},"named_entities":{"people":[{"name":"Terrence Moorehead","role":"President and CEO"}],"products":["Protandim","TrueScience Liquid Collagen","MindBody GLP-1 System","AXIO","Petandim"],"companies":[{"name":"LifeVantage Corporation","ticker":"LFVN"}],"dollarAmounts":[]},"model_name":"glm-5.3-flashx","prompt_hash":"sha256:5c812bd9e28b810d","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-10-12T20:05:04.310Z","global_importance":8,"audience_relevance":8,"importance_components":{"tickerTier":"small-cap","eventGravity":"boilerplate-equity-grant","issuerAuthored":true}},"durationMs":3937,"modelName":"glm-5.3-flashx"}}